Q J Med 2001; 94: 571-573
© 2001 Association of Physicians
Editorial |
Point-of-care testing: no pain, no gain
Consultant Chemical Pathologist, Derriford Hospital, Plymouth
Consultant Biochemist, Dumfries and Galloway Royal Infirmary, Dumfries
Simple point-of-care testing (POCT) has long been a feature of hospital wards and general practice surgeries. Familiar examples include urinalysis, blood glucose measurement and ECGs. Increasingly, however, the range of tests that can be undertaken at the point of care spans the full gamut of clinical practice.1 Markers of myocardial damage can now be measured on admission in the assessment of patients with chest pain, both for diagnosis of acute myocardial infarction and for risk stratification. Measurement of D-dimers may permit more efficient triage of patients with suspected deep-vein thrombosis. On-site screening for microbial antigens or inflammatory markers such as C-reactive protein allows rapid determination of whether or not antibiotic therapy is appropriate, in advance of
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. C. Gruszecki, G. Hortin, J. Lam, D. Kahler, D. Smith, J. Vines, L. Lancaster, T. M. Daly, C. A. Robinson, and R. W. Hardy Utilization, Reliability, and Clinical Impact of Point-of-Care Testing during Critical Care Transport: Six Years of Experience Clin. Chem., June 1, 2003; 49(6): 1017 - 1019. [Full Text] [PDF] |
||||
